Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Here's Why You Should Add OGE Stock to Your Portfolio Right Now
Here's Why You Should Add OGE Stock to Your Portfolio Right Now

OGE Energy Corp. OGE focuses on consistent investments in infrastructure upgrades to better serve its customers. The company is also steadily expanding its renewable generation assets. Given its

NANO Nuclear Energy to Report Q4 Earnings: How to Play the Stock?
NANO Nuclear Energy to Report Q4 Earnings: How to Play the Stock?

NANO Nuclear Energy Inc. NNE is scheduled to release fiscal fourth-quarter results on Dec. 18, after market close. The Zacks Consensus Estimate is currently pegged at a loss of 33 cents per share

GS Sees M&A Momentum to Continue in 2026: Implications for Its IB Fees
GS Sees M&A Momentum to Continue in 2026: Implications for Its IB Fees

The Goldman Sachs Group’s GS chief financial officer, Denis Coleman, affirmed its strong confidence in global mergers and acquisitions (M&A) at the firm’s 2025 Global Conference held on Dec 9. The

Goldman Stock Trades Near 52-Week High: How to Approach Now?
Goldman Stock Trades Near 52-Week High: How to Approach Now?

The Goldman Sachs Group GS shares have been performing remarkably well of late. At present, the stock is trading near its 52-week high of $919.10 hit during Thursday’s trading session. Over the past

CHMP Backs Higher-Dose Wegovy as Novo Nordisk Seeks 2026 EU Approval
CHMP Backs Higher-Dose Wegovy as Novo Nordisk Seeks 2026 EU Approval

Novo Nordisk NVO announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the EU approval of a higher

GSK's Nucala for COPD and Depemokimab for Asthma Get CHMP Nod in EU
GSK's Nucala for COPD and Depemokimab for Asthma Get CHMP Nod in EU

GSK plc GSK announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a positive opinion recommending the approval of Nucala as an

UNM Stock Trading at a Discount to Industry at 1.2X: Time to Hold?Photo, wide shot, wide-angle lens,  Reinsurance company, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/490045fb-8676-41a9-be7a-bcf4281c7d92.png
UNM Stock Trading at a Discount to Industry at 1.2X: Time to Hold?

Unum Group UNM shares are trading at a discount compared to the Zacks Accident and Health Insurance industry. Its forward price-to-book value of 1.2X is lower than the industry average of 1.75X, the

Should Investors Buy OKLO Stock After Its Massive 2025 Run?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, sunset photo at golden hour, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/8b396c5d-cf01-4937-89c4-91ad2f28f1ee.png
Should Investors Buy OKLO Stock After Its Massive 2025 Run?

Oklo Inc. OKLO has delivered one of the most eye-catching rallies in the market this year, climbing more than 300% as investors rushed into advanced nuclear names tied to artificial intelligence

BAX Highlights EMR-Integrated Smart Pumps Boost Patient Safety & Care
BAX Highlights EMR-Integrated Smart Pumps Boost Patient Safety & Care

Baxter International Inc. BAX recently shared real-world data at the American Society of Health-System Pharmacists (“ASHP”) 2025 Midyear Clinical Meeting, highlighting the benefits of integrating

Gencor Stock Gains Post Q4 Earnings on Strong Cash, Revenue Dip
Gencor Stock Gains Post Q4 Earnings on Strong Cash, Revenue Dip

Shares of Gencor Industries, Inc. GENC gained 4.1% since the company reported results for the quarter ended Sept. 30, 2025, against a 0.4% decline in the S&P 500 Index over the same period. Over the

McCormick's Q3 Volumes Gain Traction: What to Expect in 2026?
McCormick's Q3 Volumes Gain Traction: What to Expect in 2026?

McCormick & Company, Inc.’s MKC recent performance highlights continued volume momentum, led by the consumer segment. In the third quarter of fiscal 2025, organic net sales grew 2% year over year

Should Investors Pay a Premium for ExxonMobil Stock Now?
Should Investors Pay a Premium for ExxonMobil Stock Now?

Exxon Mobil Corporation XOM is currently considered expensive on a relative basis, with the stock trading at a 7.71x trailing 12-month Enterprise Value to Earnings Before Interest, Taxes

Can These 3 Semiconductor Stocks Lead the Next Tech Rally in 2026?Photo, wide shot, wide-angle lens,  Networking equipment supplier, sunset photo at golden hour, photo by Marc Adamus: https://img.midjourneyapi.xyz/temp/66e3509e-f4c6-4a7b-8e88-53fcc02cf17f.png
Can These 3 Semiconductor Stocks Lead the Next Tech Rally in 2026?

The bull run in equity markets in the outgoing year, following the tariff bloodbath, was largely driven by AI, with investors betting big on its inherent growth prospects. AI-based semiconductor

INOD vs. PLTR: Which AI Data Stock Has More Upside Now?Photo, wide shot, wide-angle lens,  Telecom equipment supplier, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/3967c11c-b755-4d39-87d0-acc853384c80.png
INOD vs. PLTR: Which AI Data Stock Has More Upside Now?

Artificial intelligence spending is increasingly shifting from experimentation to scaled deployment, forcing enterprises and governments to rethink how they collect, structure, govern and

4 Construction Stocks Gaining Momentum Heading Into 2026
4 Construction Stocks Gaining Momentum Heading Into 2026

U.S. construction activity is entering a more durable expansion phase as federal infrastructure spending, grid modernization, energy transition projects and data-center development converge

NET Gains From Synergy in Its AI and Security Products: What's Next?Photo, wide shot, wide-angle lens,  Telecom equipment supplier, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/ad10ed87-71d0-4096-a50b-ba9470f8264b.png
NET Gains From Synergy in Its AI and Security Products: What's Next?

Cloudflare NET has structured its product portfolio to increasingly benefit from strong synergy and seamless compatibility across its offerings. Cloudflare now commands more than 55

AMAT Gains From Traction in WFE Products: A Sign of More Upside?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.theapi.app/temp/bee95973-d201-429b-849e-52867059bd1a.png
AMAT Gains From Traction in WFE Products: A Sign of More Upside?

Applied Materials’ AMAT latest wafer fabrication equipment (WFE) is experiencing increased demand due to rising usage of semiconductors in artificial intelligence and high performance computing

META Down 19% From 52-Week High: What Awaits the Stock in 2026?
META Down 19% From 52-Week High: What Awaits the Stock in 2026?

Meta Platforms’ META shares closed at $644.23 on Dec. 12, down roughly 19.1% from the 52-week high of $796.25 it hit on Aug. 15. META shares have returned a meager 3.2% in the trailing 12-month

Best Momentum Stocks to Buy for Dec. 15Photo, wide shot, wide-angle lens,  Bank, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/094456a7-d529-4ef2-b536-c031f2afd618.png
Best Momentum Stocks to Buy for Dec. 15

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, Dec. 15:

Customers Bancorp, Inc. CUBI: This bank holding company for Customers Bank has a

Best-Performing Leveraged ETF Areas of 2025Photo, wide shot, wide-angle lens,  Consumer electronics manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/0defe5ca-333a-451e-9549-4f262e278fc7.png
Best-Performing Leveraged ETF Areas of 2025

The year 2025 began with post-election optimism and expectations of a strong first quarter. Instead, markets were hit by the rise of low-cost AI initiatives from China, and its adverse impact on the

PANW vs. CRWD: Which Cybersecurity Stock Has an Edge Right Now?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, sunset photo at golden hour, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7835e381-fcae-4834-ba93-4708292dc055.png
PANW vs. CRWD: Which Cybersecurity Stock Has an Edge Right Now?

Palo Alto Networks PANW and CrowdStrike CRWD are both at the forefront of the cybersecurity space, playing key roles in guarding organizations from extensive cyberattacks. While Palo Alto Networks

Valaris Strengthens Contract Backlog With Multi-Year Drillship AwardPhoto, wide shot, wide-angle lens,  Coal company, neutral atmosphere, photo by Galina Stepanova: https://img.theapi.app/temp/0e838f13-fa33-4583-92e9-bf3375dacf70.png
Valaris Strengthens Contract Backlog With Multi-Year Drillship Award

Valaris Limited VAL secured a multi-year $300 million contract from Shell plc SHEL for its drillship VALARIS DS-8 for the development of oil and gas resources off the coast of Brazil. Notably, SHEL

RCUS Stock Down on Decision to Discontinue GILD Partnered Study
RCUS Stock Down on Decision to Discontinue GILD Partnered Study

Shares of Arcus Biosciences, Inc. RCUS, a clinical-stage biopharmaceutical company, declined 14.4% following the announcement that its late-stage STAR-221 study was discontinued for futility.

The

Ditch the Cash, Grab the Gains: Top Mobile Payment Stocks to Buy
Ditch the Cash, Grab the Gains: Top Mobile Payment Stocks to Buy

An updated edition of the October 27, 2025 article.

Money is moving faster, smarter and increasingly without cash. Mobile payments are reshaping money flows across a connected global economy, with

Wall Street Analysts Believe Paysign (PAYS) Could Rally 65.76%: Here's is How to Trade
Wall Street Analysts Believe Paysign (PAYS) Could Rally 65.76%: Here's is How to Trade

Paysign, Inc. (PAYS) closed the last trading session at $5.49, gaining 7.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall